Innovus Pharmaceuticals 8-K Changes in Registrant's Certifying Accountant

February 1, 2012

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read the statements ofInnovus Pharmaceuticals, Inc. (Formerly North Horizon, Inc.)pertaining to our firm included under Item 4.01 of Form 8-K, to be filed on or about February 1, 2012 and agree with such statements as they pertain to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.

Sincerely,

/s/ Pritchett, Siler & Hardy, P.C.

PRITCHETT, SILER & HARDY, P.C.